When five-year-old golden doodle, Lucy, was diagnosed with T-cell lymphoma, owners Stéphanie Gauvin and Tim MacIsaac knew ...
Stephens initiated coverage of Arvinas (ARVN) with an Overweight rating and $55 price target. The firm is adding to its Biotechnology research coverage with a focus on targeted protein degradation, or ...
Axxcess Wealth Management LLC boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 38.5% during ...
Farther Finance Advisors LLC increased its stake in shares of Summit Materials, Inc. (NYSE:SUM – Free Report) by 275.7% ...
Group announced a secondary offering of about 8M shares of its common stock priced at $19.95 per share that were sold by Advent International, its major shareholder. Following the 2021 IPO, Advent ...